SCHEMBL6322371

SCHEMBL6322371

CC(=O)c1ccc(-c2ncco2)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.39
MAPT P10636 2/20 0.39
RAB9A P51151 2/20 0.39
BRD4 O60885 2/20 0.38
HSD17B1 P14061 1/20 0.38
RARA P10276 2/20 0.37
RARB P10826 2/20 0.37
RARG P13631 2/20 0.37
TYK2 P29597 1/20 0.37
S100A4 P26447 1/20 0.36
GLRA3 O75311 1/20 0.36
GLRB P48167 1/20 0.36
CFTR P13569 1/20 0.36
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36
TUBB4A P04350 2/20 0.35
TUBB P07437 2/20 0.35
TUBA3C P0DPH7 2/20 0.35
TUBA1B P68363 2/20 0.35
TUBA4A P68366 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6314788 0.77 PLOD2 (0.45) GLRA3GLRBCFTRHCRTR1HCRTR2
SCHEMBL17392139 0.76 ESR1 (0.50) MAPTSMN1; SMN2HSD17B10
SCHEMBL28594488 0.76 GRM5 (0.47) NPC1MAPTRAB9ASMN1; SMN2POLB
SCHEMBL6514687 0.74 BRD4 (0.49) MAPTBRD4HSD17B1GLRA3GLRB
SCHEMBL8684057 0.73 SMN1; SMN2 (0.51) NPC1MAPTRAB9ABRD4CFTR
SCHEMBL6313975 0.73 PIN1 (0.38) NPC1MAPTRAB9ABRD4HCRTR1
SCHEMBL18519888 0.73 MAPT (0.47) NPC1MAPTRAB9AHSD17B1S100A4
SCHEMBL9507238 0.73 BRD4 (0.48) BRD4GLRA3GLRBJAK3
SCHEMBL17392495 0.73 HSP90AA1 (0.44) BRD4TYK2HCRTR1HCRTR2
SCHEMBL18520272 0.72 KDM4E (0.47) NPC1MAPTRAB9AHSD17B1S100A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6951876-B2 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents PFIZER, INC. (US) 2005-10-04 US disclosed
US-6603008-B1 Inhibit the biosynthesis of prostaglandins by intervention of the action of the enzyme cyclooxygenase on arachidonic acid PFIZER INC. 2003-08-05 US disclosed
US-20030144280-A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents PFIZER INC. (US) 2003-07-31 US disclosed
EP-1104760-B1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents PFIZER PROD INC (US) 2003-03-12 EP disclosed
EP-1104760-A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents Pfizer Products Inc. (US) 2001-06-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144280-A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents PTGS1, PTGS2, SULT2A1 NPC1 2901/4885MAPT 4632/4885RAB9A 3772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.